Older mice treated with the vesicles perform better on memory tests, showing they can remember new objects and where objects were placed, unlike untreated mice who show memory decline.
Claim Context
Intranasal hiPSC-NSC-EVs improve recognition memory and spatial memory in aged mice, as demonstrated by increased exploration of novel objects and novel object locations in behavioral tests, indicating reversal of age-related cognitive deficits.
“Additionally, single-cell RNA sequencing conducted 7 days post-treatment revealed that hiPSC-NSC-EVs induce widespread transcriptomic changes in microglia... These changes mediated by hiPSC-NSC-EVs were also associated with improved cognitive and memory function.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether intranasal hiPSC-NSC-EVs consistently improve recognition and spatial memory across multiple aging models and cognitive test paradigms.
A systematic review and meta-analysis of all published studies using intranasal hiPSC-NSC-EVs in aged rodents, pooling data on discrimination index from NORT and OLT, with standardized protocols, blinding, and risk-of-bias assessment.
That intranasal hiPSC-NSC-EVs cause a significant improvement in recognition and spatial memory in aged mice compared to placebo.
A double-blind RCT in 120 aged C57BL/6 mice (20 months) randomized to intranasal hiPSC-NSC-EVs (12×10⁹ EVs) or vehicle, with primary endpoints: discrimination index in NORT and OLT at 4 weeks post-treatment, and secondary endpoints: latency to explore novel object/location and total exploration time.
Whether the timing of hiPSC-NSC-EVs administration (late middle age vs. old age) influences the degree of long-term memory improvement.
A prospective cohort study of 150 aged mice randomized to receive hiPSC-NSC-EVs at 18, 20, or 22 months of age, with cognitive testing (NORT, OLT) performed at 24 months to assess whether earlier intervention yields greater long-term memory preservation.
Whether aged mice with the most severe memory impairment have the highest levels of hippocampal neuroinflammation and lowest mitochondrial gene expression compared to mice with preserved memory.
A case-control study comparing 30 aged mice with severe memory impairment (NORT DI <0.2) to 30 with preserved memory (NORT DI >0.5), measuring hippocampal microglial activation, NLRP3/STING proteins, and mitochondrial gene expression prior to any intervention.
Whether there is a correlation between discrimination index in NORT and levels of hippocampal NLRP3 or mitochondrial gene expression in aged mice at a single time point.
A cross-sectional analysis of 80 aged mice measuring NORT discrimination index and correlating it with hippocampal NLRP3 protein levels and Ndufs6 mRNA expression in the same animals.